The miR-506-Induced Epithelial–Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer

Annals of Surgical Oncology

Volumn 22, Issue , 2015, Pages 1436-1443

  Sakimura, Shotaro ^a,b   Sugimachi, Keishi ^a   Kurashige, Junji ^a   Ueda, Masami ^a   Hirata, Hidenari ^a   Nambara, Sho ^a   Komatsu, Hisateru ^a   Saito, Tomoko ^a   Takano, Yuki ^a   Uchi, Ryutaro ^a   Sakimura, Etsuko ^a   Shinden, Yoshiaki ^a   Iguchi, Tomohiro ^a   Eguchi, Hidetoshi ^a   Oba, Yugo ^b   Hoka, Sumio ^b   Mimori, Koshi ^a  

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 506; TRANSCRIPTION FACTOR SLUG; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; MIRN506 MICRORNA, HUMAN; SNAI2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL;

3' UNTRANSLATED REGION; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; JAPANESE (PEOPLE); LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MKN45 CELL LINE; MKN7 CELL LINE; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; SURVIVAL RATE; TUMOR DIFFERENTIATION; APOPTOSIS; CANCER GRADING; CANCER STAGING; CELL MOTION; ENZYME IMMUNOASSAY; GENETICS; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING;

AGED; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MICRORNAS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SNAIL FAMILY TRANSCRIPTION FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84952870474     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4418-2     Document Type: Article

References (33)

1. IARC. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Retrieved 10 January 2014 at http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
2. Hohenberger P, Gretschel S. Gastic cancer. Lancet. 2003; 362:305–15.
3. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell. 2009;139:871–90.
4. Thiery JP. Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.
5. Katoh M. Epithelial–mesenchymal transition in gastric cancer (review). Int J Oncol. 2005;27:1677–83.
6. Murai T, Yamada S, Fuchs BC, et al. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer. J Surg Oncol. 2014;109:684–9.
7. Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. J Am Med Assoc. 2007;297:2360–72.
8. Bhayani MK, Calin GA, Lai SY. Functional relevance of miRNA sequences in human disease. Mutat Res. 2012;731:14–9.
9. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132:4653–62.
10. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.
11. Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 2014;1845:255–65.
12. Song F, Yang D, Liu B, et al. Integrated microRNA network analyses identify a poor prognosis subtype of gastric cancer characterized by the miR-200 family. Clin Cancer Res. 2014;20:878–89.
13. Duarte I, Llanos O. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum Pathol. 1981;12:237–42.
14. Maehara Y, Moriguchi S, Kakeji Y, et al. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery. 1991;110:820–3.
15. Okugawa Y, Inoue Y, Tanaka K, et al. Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer. Clin Exp Metastasis. 2013;30:417–29.
16. Okugawa Y, Toiyama Y, Tanaka K, et al. Clinical significance of zinc finger E-box binding homeobox 1 (ZEB1) in human gastric cancer. J Surg Oncol. 2012; 106:280–5.
17. Yang D, Sun Y, Hu L, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 2013;23:186–99.
18. Arora H, Qureshi R, Park WY. miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. PloS One. 2013;8:e64273.
19. Mori M, Mimori K, Yoshikawa Y, et al. Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery. 2002;131:S39–47.
20. Ieta K, Ojima E, Tanaka F, et al. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer. 2007;121:33–8.
21. Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009;2:18.
22. Akagawa S, Ohuchida K, Torata N, et al. Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer. Int J Oncol. 2014;45:113–20.
23. Miyake S, Kitajima Y, Nakamura J, et al. HIF-1alpha is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer. Int J Oncol. 2013;43:1431–40.
24. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 2001;3:289–93.
25. Paredes J, Figueiredo J, Albergaria A, et al. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826:297–311.
26. Yin M, Ren X, Zhang X, et al. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-kappaB p65 to evoke reactive oxygen species generation and p53 activation. Oncogene. 2014. doi: 10.1038/onc.2013.597.
27. Wen SY, Lin Y, Yu YQ, et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene. 2014. doi:10.1038/onc.2014.9.
28. Liu G, Sun Y, Ji P, et al. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. J Pathol. 2014;233:308–18.
29. Guo F, Parker Kerrigan BC, Yang D, et al. Posttranscriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions. J Hematol Oncol. 2014;7:19.
30. Liu Z, Chen L, Zhang X, et al. RUNX3 regulates vimentin expression via miR-30a during epithelial–mesenchymal transition in gastric cancer cells. J Cell Mol Med. 2014;18:610–23.
31. Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM, Beug H, Wirth T. NF-kappaB promotes epithelial–mesenchymal transition, migration, and invasion of pancreatic carcinoma cells. Cancer Lett. 2010;295:214–28.
32. Takeshita F, Patrawala L, Osaki M, et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther. 2010;18:181–7.
33. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010; 327:198–201.